ELMWOOD PARK, N.J.--(BUSINESS WIRE)--Bio-Reference Laboratories, Inc. (NASDAQ: BRLI) (Except for Per Share Data or where otherwise noted, Numbers are in Thousands) announced record-setting fourth quarter and year-end performance numbers. The Company recorded Q4FY07 revenues of $69,795, the best ever quarter in terms of revenues in corporate history and an increase of 29% over the $54,001 recorded in the fourth quarter, fiscal year 2006. Net income before taxes in Q4FY07 totaled $7,855; an increase of 22% compared with net income before taxes of $6,386 in Q4FY06. Net income after tax for Q4FY06 totaled $4,644 or $.34 per share as compared with $3,711 or $.28 per share in the corresponding quarter in FY06. Gross profits on revenues for the current quarter were $36,191 resulting in a margin for gross profit on revenues of 52%, versus the $28,600 reported for the prior fiscal year fourth quarter, which was 53%. Revenue per patient for the fourth quarter of the current fiscal year was $71.06, an increase of 6% over the $67.00 reported for the same quarter of the prior fiscal year. The number of patients served increased 22% to 972 in the current quarter from the prior year fourth quarter total of 797. Esoteric business for the Company was 45% of revenues for the fourth quarter of the current fiscal year.
